Workshop on the development of new medicines to treat tuberculosis

  • Email
  • Help

Details

TitleWorkshop on the development of new medicines to treat tuberculosis
Date25/11/2016 - 25/11/2016
LocationEuropean Medicines Agency, London, UK
SummaryThe workshop brings together experts and stakeholders from the academic, regulatory and industrial sectors to discuss key issues and new developments in the field of development of antimycobacterial medicines to treat tuberculosis. The presentations and discussions support the finalisation of the newly drafted addendum to the note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections to specifically address the clinical development of new agents to treat disease due to mycobacterium tuberculosis. The workshop will be broadcast live.

All documents

Name Language First published Last updated
Agenda - Workshop on development of antimycobacterial medicinal products (to treat Mycobacterium tuberculosis) (English only) 2016-11-15 2016-11-23
List of participants - Workshop on development of antimycobacterial medicinal products (to treat Mycobacterium tuberculosis) (English only) 2017-03-16  
Presentation - Aims and objectives of the workshop on development of antimycobacterial medicinal products (to treat Mycobacterium tuberculosis) (Mair Powell) (English only) 2017-03-16  
Presentation - Topic 1 - In vitro models and animal models (Debra Hanna) (English only) 2017-03-16  
Presentation - Topic 1 - Selection of agents, doses and regimens for clinical study (David Barros) (English only) 2017-03-16  
Presentation - Topic 2 - Efficacy endpoints in clinical trials (Lawrence Geiter) (English only) 2017-03-16  
Presentation - Topic 2 - Endpoints that may correlate with cure (Gerry Davies) (English only) 2017-03-16  
Presentation - Topic 2 - Industry developers perspective (Robert Wallis) (English only) 2017-03-16  
Presentation - Topic 2 - Trial design considerations for evaluation of new treatment regimens, an academic perspective (Andrew Nunn) (English only) 2017-03-16  
Presentation - Topic 3 - Clinical development strategies and trial designs for new TB treatment regimens, Bedaquiline case study (Myriam Theeuwes) (English only) 2017-03-16  
Presentation - Topic 3 - Clinical development strategies and trial designs for new TB treatment regimens (Carl Mendel) (English only) 2017-03-16  
Presentation - Topic 3 - Evaluation of new treatment regimens, a clinicians perspective (Andreas Diacon) (English only) 2017-03-16  
Presentation - Topic 3 - WHO perspective (Christian Lienhardt) (English only) 2017-03-16  

Media Videos

To view the broadcast, please ensure that Adobe Flash Player is installed.

Note that you should see the live broadcast or the message ‘We are currently not broadcasting’ below, on this page.  If the area below is black or in case of difficulties viewing the broadcast, please try connecting directly to our Ustream channel: European Medicines Agency or try viewing from an unrestricted connection, for example over wifi or 3G. For technical information about the required network security settings, please see this Ustream help page.

We recommend to press the ‘HD’ symbol on the player and select the option '720' to obtain the best quality of the video. For further assistance, please consult the Ustream Help Center


Registration

  • Registration by invitation only
  • Places limited

Live broadcast

  • 25 November 2016
    9:00-16:00 UK time

small format video Icon To watch the broadcast click on 'Multimedia' tab.

Related content